Next Article in Journal
Mutational Analysis of Merkel Cell Carcinoma
Next Article in Special Issue
Characterization of HGF/Met Signaling in Cell Lines Derived From Urothelial Carcinoma of the Bladder
Previous Article in Journal
From Human Papillomavirus (HPV) Detection to Cervical Cancer Prevention in Clinical Practice
Previous Article in Special Issue
Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues
Article Menu

Export Article

Open AccessReview
Cancers 2014, 6(4), 2100-2115;

MET and Small-Cell Lung Cancer

Medical Oncology Unit 1, Medical Oncology Department, Fondazione IRCCS Istituto Nazionale Tumori, Via G. Venezian 1, 20133 Milano, Italy
Operative Unit of Pathology, Azienda Ospedaliero-Universitaria Policlinico, Via del Pozzo 71, 41124 Modena, Italy
Medical Oncology Unit, Azienda Ospedaliero-Universitaria, Viale A. Gramsci 14, 43126 Parma, Italy
Author to whom correspondence should be addressed.
Received: 6 August 2014 / Revised: 21 September 2014 / Accepted: 22 September 2014 / Published: 13 October 2014
(This article belongs to the Special Issue MET in Cancer)
PDF [373 KB, uploaded 13 October 2014]


Small-cell lung cancer (SCLC) is one of the most aggressive lung tumors. The majority of patients with SCLC are diagnosed at an advanced stage. This tumor type is highly sensitive to chemo-radiation treatment, with very high response rates, but invariably relapses. At this time, treatment options are still limited and the prognosis of these patients is poor. A better knowledge of the molecular biology of SCLC allowed us to identify potential druggable targets. Among these, the MET/HGF axis seems to be one of the most aberrant signaling pathways involved in SCLC invasiveness and progression. In this review, we describe briefly all recent literature on the different molecular profiling in SCLC; in particular, we discuss the specific alterations involving c-MET gene and their implications as a potential target in SCLC. View Full-Text
Keywords: c-MET; small-cell lung cancer; mutations; c-MET signaling pathway c-MET; small-cell lung cancer; mutations; c-MET signaling pathway
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Gelsomino, F.; Rossi, G.; Tiseo, M. MET and Small-Cell Lung Cancer. Cancers 2014, 6, 2100-2115.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top